We are live on ! Find out more
TEE

Tibra Equities Europe Portfolio holdings

AUM $90.4M
1-Year Est. Return 37.81%
This Fund
S&P 500
This Quarter Est. Return
+11.58%
1 Year Est. Return
+37.81%
3 Year Est. Return
+142.96%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$324M
AUM Growth
-$3.28M
Cap. Flow
-$25M
Cap. Flow %
-7.73%
Top 10 Hldgs %
66.05%
Holding
251
New
234
Increased
3
Reduced
3
Closed
11

Top Buys

Rank Stock Value
1
KSU
Kansas City Southern
KSU
+$25.9M
2
PFPT
Proofpoint, Inc.
PFPT
+$13.6M
3
ATH
Athene Holding Ltd. Class A Common Shares
ATH
+$13M
4
SOLY
Soliton, Inc.
SOLY
+$9.27M
5
NUAN
Nuance Communications, Inc.
NUAN
+$9.14M

Top Sells

Rank Stock Value
1
WORK
Slack Technologies, Inc.
WORK
+$36.2M
2
MXIM
Maxim Integrated Products
MXIM
+$36.2M
3
RP
RealPage, Inc.
RP
+$35.2M
4
CTB
Cooper Tire & Rubber Co.
CTB
+$21.3M
5
GLUU
Glu Mobile Inc.
GLUU
+$19.2M

Sector Composition

Rank Sector Weight
1 Healthcare 22.46%
2 Financials 21.6%
3 Communication Services 13.54%
4 Industrials 9.76%
5 Technology 9.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RESN
151
DELISTED
Resonant Inc.
RESN
$319K 0.1%
+99,300
New +$341K
BFIN
152
DELISTED
BankFinancial
BFIN
$318K 0.1%
+27,800
New +$298K
OPTN
153
DELISTED
OptiNose
OPTN
$318K 0.1%
+6,820
New +$348K
NBSE
154
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
$318K 0.1%
+3,320
New +$367K
CHMI
155
Cherry Hill Mortgage Investment Corp
CHMI
$88.5M
$316K 0.1%
+32,000
New +$317K
GALT icon
156
Galectin Therapeutics
GALT
$348M
$316K 0.1%
+98,700
New +$351K
CBIO
157
Crescent Biopharma
CBIO
$626M
$316K 0.1%
+1,361
New +$346K
NERV icon
158
Minerva Neurosciences
NERV
$199M
$316K 0.1%
+17,013
New +$366K
XFOR icon
159
X4 Pharmaceuticals
XFOR
$460M
$315K 0.1%
+1,613
New +$406K
EARN
160
Ellington Residential Mortgage REIT
EARN
$165M
$314K 0.1%
+26,700
New +$330K
VYGR icon
161
Voyager Therapeutics
VYGR
$201M
$314K 0.1%
+76,000
New +$344K
LCI
162
DELISTED
Lannett Company, Inc.
LCI
$313K 0.1%
+16,775
New +$322K
ABEO icon
163
Abeona Therapeutics
ABEO
$413M
$312K 0.1%
+7,988
New +$326K
TCDA
164
DELISTED
Tricida, Inc. Common Stock
TCDA
$312K 0.1%
+72,300
New +$345K
BCML icon
165
BayCom
BCML
$333M
$311K 0.1%
+17,300
New +$314K
STRS icon
166
Stratus Properties
STRS
$154M
$311K 0.1%
+12,600
New +$363K
LJPC
167
DELISTED
La Jolla Pharmaceutical Company
LJPC
$311K 0.1%
+72,600
New +$311K
AQST icon
168
Aquestive Therapeutics
AQST
$494M
$310K 0.1%
+78,100
New +$312K
SWN
169
DELISTED
Southwestern Energy Company
SWN
$310K 0.1%
+54,600
New +$269K
OVID icon
170
Ovid Therapeutics
OVID
$491M
$308K 0.1%
+78,700
New +$311K
FONR
171
DELISTED
Fonar
FONR
$306K 0.09%
+17,300
New +$309K
GNE icon
172
Genie Energy
GNE
$383M
$306K 0.09%
+48,400
New +$297K
SHBI icon
173
Shore Bancshares
SHBI
$796M
$305K 0.09%
+18,200
New +$308K
AGTC
174
DELISTED
Applied Genetic Technologies Corporation
AGTC
$305K 0.09%
+78,100
New +$324K
NEXT icon
175
NextDecade
NEXT
$1.78B
$303K 0.09%
+73,400
New +$207K
5 6
7
8 9

Similar funds

EM
Endicott Management New York $81.7M AUM 36.01% 1-Year Est. Return
BBHBI
B, B, H, & B Inc Birmingham, Alabama $106M AUM 12.24% 1-Year Est. Return
EA
Elm Advisors Burlingame, California $74.1M AUM 7.85% 1-Year Est. Return
SCMU
Steadfast Capital Management (UK) London, United Kingdom $71.5M AUM
DCM
Dockyard Capital Management Boston, Massachusetts $70.6M AUM
BCIMC
Boyu Capital Investment Management Company Hong Kong $110M AUM 5.74% 1-Year Est. Return
LSC
Lyon Street Capital Sausalito, California $67M AUM
RCM
RVB Capital Management Great Neck, New York $117M AUM 17.05% 1-Year Est. Return

Tibra Equities Europe's Q2 2021 Portfolio in Review

As of Q2 2021, Tibra Equities Europe held 251 positions worth $324M, down 1% from $327M the previous quarter. Its ten largest holdings account for 66% of the portfolio.

Tibra Equities Europe withdrew a net $25M in Q2 2021, closing 11 positions and reducing 3 holdings. Its most notable exit was Slack Technologies, Inc., an estimated $36.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 11% a quarter earlier, followed by Financials and Communication Services.

Against the trend, Tibra Equities Europe opened a new position in Kansas City Southern worth $25.4M.

  • Tibra Equities Europe's largest Q2 2021 buy was Kansas City Southern: 89,555 shares worth $25.4M.
  • Tibra Equities Europe added most to IHS Markit Ltd. Common Shares in Q2 2021, an estimated $4.2M increase.
  • Tibra Equities Europe's biggest Q2 2021 reduction was Maxim Integrated Products, cutting an estimated $36.2M.
  • Tibra Equities Europe fully exited Slack Technologies, Inc. in Q2 2021, selling an estimated $36.2M.
  • Tibra Equities Europe's ten largest holdings make up 66% of its $324M portfolio in Q2 2021.
  • Tibra Equities Europe opened 234 new positions and closed 11 in Q2 2021.
  • Tibra Equities Europe's portfolio value fell 1% quarter-over-quarter to $324M.

Based on Tibra Equities Europe's 13F filing for Q2 2021, filed 16 Aug 2021.